Advertisement

Folia Microbiologica

, Volume 64, Issue 4, pp 587–600 | Cite as

Incidence of multidrug resistance, pathogenicity island markers, and pathoadaptive FimH mutations in uropathogenic Escherichia coli isolated from asymptomatic hospitalized patients

  • Arunita Ghosh
  • Mandira MukherjeeEmail author
Original Article

Abstract

Asymptomatic uropathogenic Escherichia coli (UPECs) are the leading cause of asymptomatic bacteriuria (ABU) in humans. So this study aimed to identify and characterize ABU UPECs from hospitalized patients of Kolkata, India, with respect to their antibiogram profile, phylogeny, pathogenicity islands, and virulence factor gene acquisition and FimH mutations in comparison to symptomatic UPECs. E. coli was detected biochemically in 44.44% (20/45) and 32.26% (20/62) of urine culture-positive asymptomatic and symptomatic hospitalized individuals respectively. Ninety-five percent of the asymptomatic isolates were multidrug resistant (MDR) compared to the symptomatic isolates (100%). Significant predominance of unknown phylogroup, pathogenicity island markers (PAI IV536, PAI I CFT073), and distribution patterns of different virulence factor genes respectively was evident among both groups. A significant correlation was observed between both groups of isolates with respect to their antibiotic resistances (except imipenem, amikacin, and nitrofurantoin), prevalence of phylogenetic groups and PAIs, and virulence factor gene (fimH, papC, papEF, papGII, iucD, and cnf1) acquisition. Pathoadaptive FimH adhesin mutations, especially hot spot mutation V27A, were detected in 80% asymptomatic isolates mostly reported in symptomatic ones worldwide. Moreover, this is the first study from India that reported incidence of “Unknown” phylogroup, pathogenicity island markers, and potentially pathoadaptive FimH mutations in asymptomatic UPECs isolated from hospitalized patients which further indicated that these ABU E. coli might have originated from their symptomatic counterparts due to unbridled use of unprescribed antibiotics. Therefore, this study demands antibiotic de-escalation along with regular and intricate monitoring at the molecular level for efficient management of ABU that addresses a major public health concern.

Notes

Acknowledgements

The authors would like to express their gratitude to Professor Nandita Basu, Director and Professor Bibhuti Saha, Head, Department of Tropical Medicine, School of Tropical Medicine, Kolkata West Bengal, India, for their kind support.

Funding

Consumable support was provided from extramural grant: Department of Science and Technology, Government of West Bengal, India (Grant No. 757 (Sanc.)/ST/P/S&T/12G-21/2014 dated 27.11.14). The work was also supported by INSPIRE fellowship grant from Department of Science &Technology, New Delhi, Government of India (No.-DST/INSPIRE Fellowship/2016/ IF160069 dated November 7, 2016).

Compliance with ethical standards

Ethical approval

The present study was approved by the Clinical Research Ethics Committee, School of Tropical Medicine, Kolkata (CREC-STM), Ref no. CREC-STM/317 dated 29/3/16, and informed consent was obtained from all patients for being included in this study.

Competing interests

The authors declare that they have no competing interests.

Supplementary material

12223_2019_685_MOESM1_ESM.docx (44 kb)
ESM 1 (DOCX 43 kb)

References

  1. Abbo LM, Hooton TM (2014) Antimicrobial stewardship and urinary tract infections. Antibiotics 3:174–192CrossRefGoogle Scholar
  2. Basu S, Mukherjee SK, Hazra A, Mukherjee M (2013) Molecular characterization of uropathogenic Escherichia coli: nalidixic acid and ciprofloxacin resistance, virulent factors and phylogenetic background. J Clin Diagn Res 7:2727–2731Google Scholar
  3. Bien J, Sokolova O, Bozko P (2012) Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int J Nephrol 2012:681473–681487CrossRefGoogle Scholar
  4. Clermont O, Christenson JK, Denamur E, Gordon DM (2013) Rapid and simple determination of the Escherichia coli phylogenetic group. Environ Microbiol Rep 5:58–65CrossRefGoogle Scholar
  5. CLSI (2018) Performance standards for antimicrobial susceptibility testing: 28th informational supplement. M100- S28. Clinical and Laboratory Standards Institute, WayneGoogle Scholar
  6. Cope M, Cevallos ME, Cadle RM, Darouiche RO, Musher DM, Trautner BW (2009) Inappropriate treatment of catheter-associated asymptomatic bacteriuria in a tertiary care hospital. Clin Infect Dis 48:1182–1188CrossRefGoogle Scholar
  7. Dreux N, Denizot J, Martinez-Medina M, Mellmann A, Billig M, Kisiela D et al (2013) Point mutations in FimH adhesin of Crohn’s disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response. PLoS Pathog 9:1003141–1003157CrossRefGoogle Scholar
  8. Elzayat MA, Barnett-Vanes A, Dabour MF, Cheng F (2017) Prevalence of undiagnosed asymptomatic bacteriuria and associated risk factors during pregnancy: a cross-sectional study at two tertiary centres in Cairo, Egypt. BMJ Open 7:013198–013204Google Scholar
  9. Hommais F, Gouriou S, Amorin C, Bui H, Rahimy MC, Picard B et al (2003) The FimH A27V mutation is pathoadaptive for urovirulence in Escherichia coli B2 phylogenetic group isolates. Infect Immun 71:3619–3622CrossRefGoogle Scholar
  10. Iebba V, Conte MP, Lepanto MS, Di Nardo G, Santangelo F, Aloi M et al (2012) Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease. Infect Immun 80:1408–1417CrossRefGoogle Scholar
  11. Iranpour D, Hassanpour M, Ansari H, Tajbakhsh S, Khamisipour G, Najafi A (2015) Phylogenetic groups of Escherichia coli strains from patients with urinary tract infection in Iran based on the new Clermont phylotyping method. Biomed Res Int 2015:846219–846225CrossRefGoogle Scholar
  12. Kawamura-Sato K, Yoshida R, Shibayama K, Ohta M (2010) Virulence genes, quinolone and fluoroquinolone resistance, and phylogenetic background of uropathogenic Escherichia coli strains isolated in Japan. Jpn J Infect Dis 63:113–115Google Scholar
  13. Khawcharoenporn T, Vasoo S, Ward E, Singh K (2011) Abnormal urinalysis finding triggered antibiotic prescription for asymptomatic bacteriuria in the ED. Am J Emerg Med 29:828–830CrossRefGoogle Scholar
  14. Kryger J, Burleigh A, Christensen M, Hopkins W (2015) Genetic evaluation of E. coli strains isolated from asymptomatic children with neurogenic bladders. Int J Chronic Dis 2015:206570–206574Google Scholar
  15. Lee S, Yu JK, Park K, Oh EJ, Kim SY, Park YJ (2010) Phylogenetic groups and virulence factors in pathogenic and commensal strains of Escherichia coli and their association with blaCTX-M. Ann Clin Lab Sci 40:361–367Google Scholar
  16. Lutay N, Ambite I, Gronberg Hernandez J, Rydstrom G, Ragnarsdottir B, Puthia M et al (2013) Bacterial control of host gene expression through RNA polymerase II. J Clin Invest 123:2366–2379CrossRefGoogle Scholar
  17. Mabbett AN, Ulett GC, Watts RE, Tree JJ, Totsika M, Ong CL et al (2009) Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol 299:53–63CrossRefGoogle Scholar
  18. Mukherjee M, Koley S, Mukherjee S, Basu S, Ghosh B, Chakraborty S (2015) Phylogenetic background of E. coli isolated from asymptomatic pregnant women from Kolkata, India. J Infect Dev Ctries 9:720–724CrossRefGoogle Scholar
  19. Naderi G, Haghi F, Zeighami H, Hemati F, Masoumian N (2016) Distribution of pathogenicity island (PAI) markers and phylogenetic groups in diarrheagenic and commensal Escherichia coli from young children. Gastroenterol Hepatol Bed Bench 9:316–324Google Scholar
  20. Najafi A, Hasanpour M, Askary A, Aziemzadeh M, Najmeh Hashemi N (2017) Distribution of pathogenicity island markers and virulence factors in new phylogenetic groups of uropathogenic Escherichia coli isolates. Folia Microbiol 63:335–343CrossRefGoogle Scholar
  21. Phillips CD, Adepoju O, Stone N, Moudouni DK, Nwaiwu O, Zhao H et al (2012) Asymptomatic bacteriuria, antibiotic use, and suspected urinary tract infections in four nursing homes. BMC Geriatr 12:73–80CrossRefGoogle Scholar
  22. Roos V, Nielsen EM, Klemm P (2006) Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition. FEMS Microbiol Lett 262:22–30CrossRefGoogle Scholar
  23. Sabaté M, Moreno E, Pérez T, Andreu A, Prats G (2006) Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin Microbiol Infect 12:880–886CrossRefGoogle Scholar
  24. Samei A, Haghi F, Zeighami H (2015) Distribution of pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Folia Microbiol 61:261–268CrossRefGoogle Scholar
  25. Srivastava R, Srivastava S, Agarwal J, Mishra B (2016) Virulence versus fitness determinants in Escherichia coli isolated from asymptomatic bacteriuria in healthy nonpregnant women. Indian J Med Microbiol 34:46–51CrossRefGoogle Scholar
  26. Tiba MR, Yano T, Leite DS (2008) Genotypic characterization of virulence factors in Escherichia coli strains from patients with cystitis. Rev Inst Med Trop Sao Paulo 50:255–260CrossRefGoogle Scholar
  27. Venkatesan KD, Chander S, Loganathan K, Victor K (2017) Study on asymptomatic bacteriuria in diabetic patients. Int J Contemp Med Res 4:480–483Google Scholar
  28. Zdziarski J, Svanborg C, Wullt B, Hacker J, Dobrindt U (2008) Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation? Infect Immun 76:695–703CrossRefGoogle Scholar

Copyright information

© Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i. 2019

Authors and Affiliations

  1. 1.Department of Biochemistry and Medical BiotechnologySchool of Tropical MedicineKolkataIndia

Personalised recommendations